BeyondSpring BYSI
NASDAQ BYSI
$0.43 -0.01 (-3.15%)
At close: Oct 23, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Gains from Sales and Divestitures (2025)

Updated

BeyondSpring (BYSI) reported Gains from Sales and Divestitures of -$37,000 for FY2023.

Analysis

BeyondSpring (BYSI) Gains from Sales and Divestitures (2025) Analysis & Trends

  • The FY2023 figure ranks as the highest annual Gains from Sales and Divestitures since FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 BeyondSpring 17.74 Mn 11.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 6.99 Mn
API Access

BeyondSpring Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BYSI&period=max&api_key=YOUR_API_KEY